Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels

被引:0
|
作者
J. Kiehn
Dierk Thomas
Christoph A. Karle
Wolfgang Schöls
Wolfgang Kübler
机构
[1] Department of Cardiology,
[2] Medical Hospital,undefined
[3] University of Heidelberg,undefined
[4] Bergheimerstrasse 58,undefined
[5] D-69115 Heidelberg,undefined
[6] Germany e-mail: johann kiehn@UKL.uni-heidelberg.de,undefined
[7] Fax: +49-6221-565515,undefined
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 1999年 / 359卷
关键词
Key words HERG; Potassium channel; Delayed rectifier; Amiodarone; Arrhythmia; “Torsade de pointes”; Class III antiarrhythmic drug;
D O I
暂无
中图分类号
学科分类号
摘要
The human ether-a-go-go-related gene (HERG) encodes a K+ channel with biophysical properties nearly identical to the rapid component of the cardiac-delayed rectifier K+ current (IKr). HERG channels are one primary target for the pharmacological management of arrhythmias. In this study, we investigated the acute effects of the class III antiarrhythmic drug amiodarone on HERG channels expressed heterologously in Xenopus oocytes by use of the two-microelectrode voltage clamp technique. Amiodarone blocked HERG channels with an IC50 of 9.8 µM with a maximum outward tail current reduction of 62.8%. The block consisted of two main components, a closed channel block that could not be reversed within the time of experiments and an open channel block with a slow unblock, having a recovery time constant of 73 s at –80 mV. Inactivation of the HERG channel at very positive potentials could not prevent amiodarone block. These results indicate that HERG channels can be blocked by amiodarone in closed, open and inactivated states. The block of open channels was cumulative, use-dependent and voltage-dependent. In summary, our data suggest that the strong class III antiarrhythmic action of amiodarone is at least partially based upon its acute inhibitory effects on HERG potassium channels.
引用
收藏
页码:212 / 219
页数:7
相关论文
共 50 条
  • [41] Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes
    Rolf, S
    Haverkamp, W
    Borggrefe, M
    Musshoff, U
    Eckardt, L
    Mergenthaler, J
    Snyders, DJ
    Pongs, O
    Speckmann, EJ
    Breithardt, G
    Madeja, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (01) : 22 - 31
  • [42] POTASSIUM CHANNELS AS TARGETS FOR ANTIARRHYTHMIC DRUG-ACTION
    COLATSKY, TJ
    FOLLMER, CH
    DRUG DEVELOPMENT RESEARCH, 1990, 19 (02) : 129 - 140
  • [43] ARRHYTHMOGENIC CORRELATES OF CLASS-III ANTIARRHYTHMIC AGENTS - FOCUS ON AMIODARONE
    SINGH, BN
    TAKANAKA, C
    CURRENT TOPICS IN ANTIARRHYTHMIC AGENTS: MODE OF ACTION AND CLINICAL USAGE, 1989, 56 : 117 - 131
  • [44] Comparison of inhibitory effects on HERG potassium channels of the class Ic anti-arrhythmic agent flecainide with the class la agent quinidine and class Ib agent lignocaine
    Paul, AA
    Witchel, HJ
    Hancox, JC
    JOURNAL OF PHYSIOLOGY-LONDON, 2001, 536 : 78P - 79P
  • [45] Amiodarone: an effective antiarrhythmic drug with unusual side effects
    van Erven, Lieselot
    Schalij, Martin J.
    HEART, 2010, 96 (19) : 1593 - 1600
  • [46] Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action
    Claudia Kiesecker
    Edgar Zitron
    Sonja Lück
    Ramona Bloehs
    Eberhard P. Scholz
    Sven Kathöfer
    Dierk Thomas
    Volker A. W. Kreye
    Hugo A. Katus
    Wolfgang Schoels
    Christoph A. Karle
    Johann Kiehn
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 370 : 423 - 435
  • [47] Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels:: mode of action
    Kiesecker, C
    Zitron, E
    Lück, S
    Bloehs, R
    Scholz, EP
    Kathöfer, S
    Thomas, D
    Kreye, VAW
    Katus, HA
    Schoels, W
    Karle, CA
    Kiehn, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (06) : 423 - 435
  • [48] Differences in QTC interval between male and female subjects prescribed the class III antiarrhythmic drug amiodarone.
    Thomas, SH
    El Eraky, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P96 - P96
  • [49] Inhibition of HERG potassium channel current by the Class 1a antiarrhythmic agent disopyramide
    Paul, AA
    Witchel, HJ
    Hancox, JC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (05) : 1243 - 1250
  • [50] Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform
    Du, C. Y.
    El Harchi, A.
    McPate, M. J.
    Orchard, C. H.
    Hancox, J. C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 405 (02) : 222 - 227